Free Trial

State of Wyoming Raises Position in Trupanion, Inc. (NASDAQ:TRUP)

Trupanion logo with Finance background

State of Wyoming grew its stake in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 111.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,158 shares of the financial services provider's stock after purchasing an additional 5,880 shares during the quarter. State of Wyoming's holdings in Trupanion were worth $538,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of TRUP. Balyasny Asset Management L.P. lifted its stake in Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after acquiring an additional 661,559 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in Trupanion by 170.7% during the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after purchasing an additional 212,545 shares during the last quarter. Freestone Grove Partners LP bought a new stake in Trupanion in the 4th quarter worth about $7,776,000. Baillie Gifford & Co. increased its stake in Trupanion by 26.6% in the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after buying an additional 147,341 shares during the last quarter. Finally, First Trust Advisors LP bought a new position in shares of Trupanion during the 4th quarter worth approximately $7,083,000.

Insider Transactions at Trupanion

In related news, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $4,415,201.28. The trade was a 3.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 1,373 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the transaction, the chief financial officer now directly owns 2,416 shares of the company's stock, valued at $82,675.52. The trade was a 36.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,792 shares of company stock worth $1,122,802 over the last quarter. Corporate insiders own 5.42% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on TRUP shares. Lake Street Capital reduced their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a report on Friday, May 2nd. Stifel Nicolaus reduced their price objective on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research note on Thursday, February 20th. Finally, Piper Sandler lowered their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research note on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $51.80.

Check Out Our Latest Report on Trupanion

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $46.15 on Tuesday. The stock has a fifty day simple moving average of $38.21 and a two-hundred day simple moving average of $44.13. Trupanion, Inc. has a 1-year low of $25.90 and a 1-year high of $57.90. The firm has a market cap of $1.97 billion, a price-to-earnings ratio of -200.65, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm had revenue of $341.98 million for the quarter, compared to analysts' expectations of $337.81 million. During the same quarter in the prior year, the firm earned ($0.16) EPS. The business's revenue for the quarter was up 11.7% compared to the same quarter last year. Analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Trupanion Company Profile

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Read More

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP - Free Report).

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines